Last reviewed · How we verify

NCT05822063

The Effect of Cold Packs, Lidocaine and Flash Lights on Cannulation Pain in Hemodialysis Patients

Status unknown Phase 3 Last updated 20 July 2023
What this trial tests

Phase 3 trial testing Lidocaine topical in Arteriovenous Graft Site Pain in 108 participants. Status unknown.

Timeline
25 July 2023
Primary endpoint
25 August 2023
1 September 2023

Quick facts

Lead sponsorAin Shams University
PhasePhase 3
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment108
Start date25 July 2023
Primary completion25 August 2023
Estimated completion1 September 2023

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 18 to 70, any sex, with Arteriovenous Graft Site Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Compare the effects of lidocaine ,ice packs and flash lights on the intensity of pain induced by arteriovenous cannulation in hemodialysis patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Lidocaine topical

Trials testing the same drug.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05822063.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing